A Study to Assess utiLity of BIoEP as an Early Prognostic Indicator for Predicting Anti-Seizure Medication (ASM) Efficacy
NCT06354868
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
158
Enrollment
INDUSTRY
Sponsor class
Conditions
Epilepsy
Sponsor
Neuronostics Ltd
Collaborators
[object Object]